共 50 条
- [24] The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data Acta Pharmacologica Sinica, 2015, 36 : 841 - 846
- [27] Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years (vol 91, pg 2631, 2007) JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (08): : 3032 - 3032